evetiracetam in migraine headaches of childre

Phase 3

• Conditions: Migraine.; Migraine

• Registration Number: IRCT20171212037850N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

All of children with migraine headache with or without aura, at least two attack per week or four attack per month, so that the attacks cause them to consume the analgesics or interfere with everyday activities

Exclusion Criteria

Epilepsy
Complicated migraine
Not having the ability to record data related to the number, duration, and severity of headaches
Use of other prophylactic drugs other than Levetiracetam and Amitriptyline
Severe psychiatric problems like depression and ADHD
Hypersensitivity to tricyclic anti depressants drugs
Taking analgesic more than 4 times a week for migraine headache

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of headache. Timepoint: Before, one month later, two months later and three months after treatment began. Method of measurement: Daily Headache Registration Form.;Headache severity. Timepoint: Before, one month later, two months later and three months after treatment began. Method of measurement: Wong-Baker FACES Pain Rating Scale.;Headache frequency. Timepoint: Before, one month later, two months later and three months after treatment began. Method of measurement: Record daily diary of headache.;Improving the quality of life. Timepoint: Before, one month later, two months later and three months after treatment began. Method of measurement: PedMIDAS quality of life checklist.